×

News publications and other organizations are encouraged to reuse Direct Relief-published content for free under a Creative Commons License (Attribution-Non-Commercial-No Derivatives 4.0 International), given the republisher complies with the requirements identified below.

When republishing:

  • Include a byline with the reporter’s name and Direct Relief in the following format: "Author Name, Direct Relief." If attribution in that format is not possible, include the following language at the top of the story: "This story was originally published by Direct Relief."
  • If publishing online, please link to the original URL of the story.
  • Maintain any tagline at the bottom of the story.
  • With Direct Relief's permission, news publications can make changes such as localizing the content for a particular area, using a different headline, or shortening story text. To confirm edits are acceptable, please check with Direct Relief by clicking this link.
  • If new content is added to the original story — for example, a comment from a local official — a note with language to the effect of the following must be included: "Additional reporting by [reporter and organization]."
  • If republished stories are shared on social media, Direct Relief appreciates being tagged in the posts:
    • Twitter (@DirectRelief)
    • Facebook (@DirectRelief)
    • Instagram (@DirectRelief)

Republishing Images:

Unless stated otherwise, images shot by Direct Relief may be republished for non-commercial purposes with proper attribution, given the republisher complies with the requirements identified below.

  • Maintain correct caption information.
  • Credit the photographer and Direct Relief in the caption. For example: "First and Last Name / Direct Relief."
  • Do not digitally alter images.

Direct Relief often contracts with freelance photographers who usually, but not always, allow their work to be published by Direct Relief’s media partners. Contact Direct Relief for permission to use images in which Direct Relief is not credited in the caption by clicking here.

Other Requirements:

  • Do not state or imply that donations to any third-party organization support Direct Relief's work.
  • Republishers may not sell Direct Relief's content.
  • Direct Relief's work is prohibited from populating web pages designed to improve rankings on search engines or solely to gain revenue from network-based advertisements.
  • Advance permission is required to translate Direct Relief's stories into a language different from the original language of publication. To inquire, contact us here.
  • If Direct Relief requests a change to or removal of republished Direct Relief content from a site or on-air, the republisher must comply.

For any additional questions about republishing Direct Relief content, please email the team here.

Medicines360 and Direct Relief Partner to Expand Access for U.S. Women

The partnership will offer hormonal IUD birth control free of charge to clinics that serve the most vulnerable women in the United States.

News

Medicines360

Direct Relief and Medicines 360 are partnering to distribute IUDs to participating clinics across the U.S., providing women with no-cost birth control. (Lara Cooper/Direct Relief)
By Staff

Medicines360, a mission-driven women’s health pharmaceutical nonprofit and Direct Relief, a humanitarian aid organization, today announced their partnership to provide Medicines360’s hormonal IUD, LILETTA®, free of charge to clinics that serve the most vulnerable women in the United States, such as uninsured women. Medicines360 established an institutional patient assistance program (IPAP) known as the “IUD Access Partnership,” with Direct Relief to provide IUDs to clinics that serve women who cannot obtain the product through private insurance, Medicaid or other public funding.

This partnership marks the first consistent supply of contraceptives offered through Direct Relief. In addition, this joint endeavor represents a new, groundbreaking approach for expanding contraceptive access at a critical moment in history for women’s reproductive rights.

“A woman should be able to choose if and when she becomes pregnant, but in the United States, not every woman has that luxury,” said Jessica Grossman, MD, CEO of Medicines360. “Unfortunately, access to the most effective forms of contraception, like IUDs, is an issue for many clinics where low-income women seek care. This partnership delivers on our mission to expand access for the women who need it most, allowing them to avoid unplanned pregnancy if they choose.”

IPAPs provide drugs and medical supplies free of charge via bulk shipments to specific, vetted institutions. With an IPAP for the hormonal IUD, a woman can receive an IUD the same day she visits the clinic. This simplified process will eliminate the expense and inconvenience of a return trip, which is often prohibitive for women of lower incomes.

“This partnership reaffirms our shared commitment to filling the gaps in women’s health. Direct Relief’s collaboration with Medicines360 demonstrates the power of two mission-driven organizations joining forces to tackle issues that affect reproductive care, and we look forward to meeting the needs of underserved women across the country,” said Thomas Tighe, Direct Relief President and CEO.

IUD Access Partnership enables increased access to IUDs, a form of long-acting reversible contraceptives (LARCs), which are among the most effective forms of family planning according to the CDC. This is all possible through Direct Relief’s scalable program that delivers essential medical resources by working with pharmaceutical manufacturers and local healthcare providers.

Filed Under: , , ,

Giving is Good Medicine

You don't have to donate. That's why it's so extraordinary if you do.